Jubilant HollisterStier Contract Manufacturing

Article

Sponsored Content

Jubilant HollisterStier Contract Manufacturing is an integrated contract manufacturer, able to manufacture sterile injectable, ointment, cream, and liquid dosage forms. Our facilities across North America provide specialized manufacturing services for the pharmaceutical and biopharmaceutical industries.   Fill/Finish; Lyophilization; Multiple Dosage Forms; Certified Project Managers

Jubilant HollisterStier Contract Manufacturing  
A Jubilant Pharma Company  
3525 N. Regal St. Spokane, WA 99207    
info@jublHS.com  
tel. 509.489.5656
INTERPHEX Booth #1830

Recent Videos
Industry Outlook 2025: The Rising Prominence of AI in Pharma
Leroy Hood, MD, PhD
Behind the Headlines, Episode 10
Related Content
Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - stock.adobe.com

FDA Approves AbbVie Treatment for Complicated Intra-Abdominal Infections

Patrick Lavery
February 10th 2025
Article

These infections can be caused by certain Gram-negative microorganisms, making the infections challenging to control due to high antimicrobial resistance.

Drug Solutions Podcast: Forecasting Pharma’s Future

Drug Solutions Podcast: Forecasting Pharma’s Future

Felicity Thomas
January 31st 2025
Podcast

This episode is a compilation of comments taken from a series of interviews where experts reveal the trends that have impacted the bio/pharma industry in 2024 and those they expect to be impactful in 2025.

Group of participants engaging in interactive business seminar, with one individual raising hand while seated and another person presenting in background with laptop | Image Credit: © Seventyfour - stock.adobe.com

Split Opinions on Training Strategies

Patrick Lavery
February 9th 2025
Article

Survey results show that being intellectually stimulated and getting assigned challenging projects are two key drivers of employee satisfaction, yet job training is lacking.

Drug Solutions Podcast: Realizing AI’s Potential

Drug Solutions Podcast: Realizing AI’s Potential

Felicity Thomas
December 20th 2024
Podcast

This episode is a compilation of comments taken from a series of interviews where experts are discussing how AI might impact the global bio/pharma industry in the future.

Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - stock.adobe.com

AdvanCell Completes $112 Million Oversubscribed Series C Financing

Patrick Lavery
February 7th 2025
Article

Patient enrollment is currently underway for the highest-dose cohort of AdvanCell’s potentially best-in-class targeted alpha therapy for metastatic prostate cancer.

Hand of young man with pill, closeup. Image Credit: ©Africa Studio - stock.adobe.com

Evolving Approaches to Taste Masking

Cynthia A. Challener
February 7th 2025
Article

Increasing API and formulation complexity and new delivery strategies are driving innovations in taste-masking.